Offers In-Person and Virtual Access to Education, Support, and Community Eos Connection is more than a confere ...

Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab ...

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved ...

Feb. 3, 2025 — A multi-institutional study has identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. This is the first time ...

Sanofi presents positive results from DISCOVER phase 4 study of Dupixent in atopic dermatitis patients with skin of colour at 2025 RAD conference: Paris Tuesday, June 10, 2025, 16 ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Currituck County has announced that staff began assembling Narcan safety kits on June 12 that will be distributed in the community. Each kit contains Narcan, medicine disposal materials, and ...

Atopic dermatitis manifests differently in patients with darker skin color, according to the companies, including subtler ...

While treatment of EoE is complicated by a number of different factors, consensus would support that symptom reduction/resolution should be a primary goal in the care of patients by practicing ...

Patients with eosinophilic esophagitis in the US have high health care resource utilization costs, according to a retrospective national claims study.

Rheumatoid arthritis (RA) can progress through four stages, from early inflammation to severe joint damage, with stage 3 showing bone erosion and cartilage wear, and stage 4 (end-stage ...

immunologist and Vice President of Clinical and Translational Medicine at Knopp Biosciences, a privately-held drug discovery and development company based in Pittsburgh. Dexpramipexole ...